Child mortality infected with HIV1 followed in 40 pediatric care sites in Togo
Keywords:
Mortality, children, HIV, TogoAbstract
Introduction: The infection in pediatric HIV is the reason a lot of problems in Africa The objective of our study were to identify factors associated with mortality during follow-up of children receiving antiretroviral therapy in Togo.
Methods: It was a cross-sectional study of 870 children aged files from 7 weeks to 15 years infected with HIV on antiretroviral treatment, covering the period 1 January 2001 to 31 December 2010 taking in 40 sites medical management in Togo. Data processing was done with the software Epi-Info 6.04d and duplicates were treated by the Software ESOPE.
Results: All patients were infected with HIV-1. In total forty six (46) deaths is 5.29% of the overall cohort were reported in our series. The lethality of the overall cohort followed for 60 months was 5.29%. The survival rate of the overall effective monitoring in our study was 89.2%. Fifty-eight percent (58%) of deaths had affected children in a state of severe malnutrition and forty two percent (42%) in a state of moderate malnutrition. Sixty two percent (62%) of children under HAART treatment died benefited monitoring a psychologist.
Conclusion: The diagnostic inadequacies of pediatric HIV strike the prognosis of infected children. Efforts still needs to be done to improve the load take pediatric HIV in Togo.
Downloads
References
ONUSIDA. Rapport sur l'épidémie mondiale du SIDA. Genève : ONUSIDA ; 2013 : 56 pages. Disponible sur : URL : http://www.unaids.org.
Programme National de Lutte contre le SIDA et les Infections Sexuellement Transmissibles (PNLS-Togo). Rapport PNLS 2011. Lomé : Ministère de la Santé ; 2011 : 94 pages
Tette EMA, Neizer M, Nyarko MY, et al. Changing Patterns of Disease and Mortality at the Children's Hospital, Accra: Are Infections Rising? PLoS ONE. 2016; 11(4): e0150387. doi:10.1371/journal.pone.0150387.
Koueta F, Ouedraogo S.O, Boly C, et al. Morbidité et mortalité de l'infection à virus de l'immunodéficience humaine chez l'enfant en milieu hospitalier à Ouagadougou (Burkina Faso). Médecined'Afrique Noire.2016 ; vol. 63, N°4.
Ekouevi DK, Azondekon A, Dicko F, et al. 12-month mortality and loss-to-program in antiretroviral-treated children: The DEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health 2011; 11:519-29.
Janneke HVD, Sutcliffe CG, Munsanje B, et al. HIV-Infected Children in Rural Zambia Achieve Good Immunologic and Virologic Outcomes Two Years after Initiating Antiretroviral Therapy. PLoS ONE 2011; 6(4): e19006.
Janssen N, Ndirangu J, Newell M-L, et al. Successful paediatric HIV treatment in rural primary care in Africa.Arch Dis Child2010; 95:414-21.
Anaky M-F, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children inCôte d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ 2010;88:490-499.
Wamalwa DC, Obimbo EM, Farquhar C, et al.Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.BMC Pediatrics2010;10:33-41
Brady MT, Oleske JM, Williams PL, et al. Declines in Mortality Rates and Changes in Causes of Death in HIV-1-Infected Children during the HAART Era. J Acquir Immune DeficSyndr. 2010; 53(1): 86-94.
Edmonds A, Yotebieng M, Lusiama J, et al. The Effect of Highly Active Antiretroviral Therapy on the Survival of HIV-Infected Children in a Resource-Deprived Setting: A Cohort Study. PLoS Med. 2011;8(6): e1001044.
Davies M-A, Egger M, Keiser O, et al. Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies. Afr J AIDS Res. 2009; 8(3): 329-38.
